On May 24, 2018, the United States Food and Drug Administration (US FDA)
released a statement on GR2E Golden Rice, a rice genetically engineered to
produce provitamin A carotenoids. The US FDA statement concurs with the
assessment of the International Rice Research Institute (IRRI) regarding the
safety and nutrition of Golden Rice.
The US FDA approval is the third positive food safety evaluation of Golden
Rice, after the approvals granted by Food Standards Australia New Zealand
(FSANZ) and Health Canada in February and March 2018, respectively.
"Each regulatory application that Golden Rice completes with national
regulatory agencies takes us one step closer to bringing Golden Rice to the
people who need it the most," says IRRI Director General Matthew Morell. He
added that the rigorous safety standards observed by the US FDA and other
agencies provide a model for decision-making in all countries wishing to
reap the benefits of Golden Rice.